Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/06/1996 | CA2211788A1 Multiple drug resistance gene of aspergillus flavus |
09/06/1996 | CA2211682A1 Multiple drug resistance gene of aspergillus fumigatus |
09/06/1996 | CA2188575A1 Gene transfer-mediated angiogenesis therapy |
09/04/1996 | EP0730029A2 Actinoplanes sp. biosynthetic pathway genes for acarbose, isolation and use |
09/04/1996 | EP0729975A1 Ecdn protein and dna coding for the same |
09/04/1996 | EP0729973A1 Antigen peptide compound and immunoassay method |
09/04/1996 | EP0729784A1 Adsorbent for interleukins, method of removal thereof by adsorption, and device for adsorption |
09/04/1996 | EP0729580A1 Method of identifying hdm-2-specific antibodies |
09/04/1996 | EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
09/04/1996 | EP0729513A1 Analog of haemophilus hin47 with reduced protease activity |
09/04/1996 | EP0729511A1 Compositions and methods for utilizing conditionally lethal genes |
09/04/1996 | EP0729509A1 Vaccine against mumps containing a jeryl-lynn virus strain |
09/04/1996 | EP0729506A1 Myocardial grafts and cellular compositions useful for same |
09/04/1996 | EP0729475A1 Purification of hemoglobin |
09/04/1996 | EP0729361A1 Method of treating neurological disorders |
09/04/1996 | EP0729350A1 Hydrophobic preparations |
09/04/1996 | EP0729325A1 Osteogenic product and process |
09/04/1996 | EP0729300A1 Novel fas protein and methods of use thereof |
09/04/1996 | EP0667896A4 Direct selection of cells by secretion product. |
09/04/1996 | EP0643776B1 Nucleotidique sequences obtained from genes coding pectate-lyases, and utilizations thereof particularly for the detection of bacteria of the genus erwinia |
09/04/1996 | EP0630384A4 Methods and compounds for prevention of graft rejection. |
09/04/1996 | EP0560932B1 Methods and compositions for the suppression of neu mediated transformation |
09/04/1996 | EP0546127B1 Biosynthetic cerebrospinal fluid control and process for its production |
09/04/1996 | EP0528827B1 Protein partner screening assays and uses thereof |
09/04/1996 | EP0506884B1 Method of delivering molecules into eukaryotic cells |
09/04/1996 | EP0491014B1 Sm-D ANTIGEN PEPTIDES AND THEIR USE, IN PARTICULAR, FOR THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS |
09/04/1996 | EP0463115B1 Acetylated heterologous polypeptides |
09/04/1996 | EP0458878B1 Monoclonal antibody to novel antigen associated with human tumors |
09/04/1996 | EP0420911B1 Gene therapy using gene fusions for genetic or acquired disorders |
09/04/1996 | CN1130402A Pro-urokinase mutants |
09/04/1996 | CN1130386A Heparin functional affinity supports |
09/04/1996 | CN1130353A Protein purification |
09/04/1996 | CN1130193A Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor (EGF-R) and its diagnosis and therapeutical use |
09/04/1996 | CN1032693C Growth hormone for hepatocyte |
09/03/1996 | US5552529 Particularly interesting new cys-his protein, removal of senescent cells |
09/03/1996 | US5552528 Bovine b-endothelial cell growth factor |
09/03/1996 | US5552527 Genetic engineering method for increasing resistance to plant diseases |
09/03/1996 | US5552526 Genetic engineering and dna sequences |
09/03/1996 | US5552525 Radiodiagnostic reagents using peptides for detection of infections |
09/03/1996 | US5552524 Anti-obesity proteins |
09/03/1996 | US5552523 Anti-obesity proteins |
09/03/1996 | US5552522 Anti-obesity proteins |
09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
09/03/1996 | US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
09/03/1996 | US5552384 Antiherpes compositions and method of use |
09/03/1996 | US5552381 Recombinantly produced human membrane cofactor protein (MCP) pharmaceutical composition, and method of inhibiting complement activity |
09/03/1996 | US5552314 Cloning dna using genetic engineering in host cells |
09/03/1996 | US5552312 Recombinant HTm4 gene, protein and assays |
09/03/1996 | US5552308 CDNA clone of a rat serotonin transporter and protein encoded thereby |
09/03/1996 | US5552304 Polypeptide plasmid vectors for dna sequences |
09/03/1996 | US5552303 DNA encoding epithelium-derived T-cell factor |
09/03/1996 | US5552302 Gene expression with cloning of genes for enzyme inhibitors |
09/03/1996 | US5552300 T cell antigen receptor V region proteins and methods of preparation thereof |
09/03/1996 | US5552299 Plasmids and process for producing recombinant desulphatohirudin HV-1 peptides |
09/03/1996 | US5552289 cDNA encoding the long isoform of the D2 dopamine receptor |
09/03/1996 | US5552286 Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
09/03/1996 | US5552284 Detection of interleukin-8 receptors by nudeic acid hybridization |
09/03/1996 | US5552282 Diagnosis of myotonic muscular dystrophy |
09/03/1996 | US5552281 Human osteoclast-specific and -related genes |
09/03/1996 | US5552271 RXR homodimer formation |
09/03/1996 | US5552161 Low viscosity, highly concentrated surfactant suspension |
09/03/1996 | US5552146 Methods and compositions relating to useful antigens of Moraxella catarrhalis |
09/03/1996 | US5552144 Immunogenic shiga-like toxin II variant mutants |
09/03/1996 | US5552143 Recombinant cytomegalovirus vaccine |
09/03/1996 | US5552142 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
09/03/1996 | US5552140 Isolated protein having specified amino acid sequence |
09/03/1996 | US5552086 Gold and silver on polystyrene, useful for raman spectroscopy and flow cytometry, interlayer of aminodextran |
09/03/1996 | CA2170577A1 Acarbose biosynthesis genes from actinoplanes sp., process for the isolation thereof and the use thereof |
09/03/1996 | CA1338584C Superactive human insulin analogues |
09/03/1996 | CA1338583C Process for the preparation of peptides by use of perchlorates |
09/03/1996 | CA1338570C Endowing cells with antibody specificity |
09/02/1996 | CA2170839A1 Bacterial preparations, method for producing same, and their use as vaccines |
08/29/1996 | WO1996026292A1 Interleukin-2 signal transducers and binding assays |
08/29/1996 | WO1996026286A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
08/29/1996 | WO1996026282A1 Expression of gene products from genetically manipulated strains of bordetella |
08/29/1996 | WO1996026281A1 Chimeric adenoviral fiber protein and methods of using same |
08/29/1996 | WO1996026279A1 Human dnase i variants |
08/29/1996 | WO1996026277A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
08/29/1996 | WO1996026276A1 SecA GENE OF MYCOBACTERIUM TUBERCULOSIS AND RELATED METHODS AND COMPOSITIONS |
08/29/1996 | WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
08/29/1996 | WO1996026274A1 Antagonists of interleukin-15 |
08/29/1996 | WO1996026273A1 Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery |
08/29/1996 | WO1996026272A1 Prostate-specific membrane antigen and uses thereof |
08/29/1996 | WO1996026271A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
08/29/1996 | WO1996026268A1 Transgenically produced antithrombin iii |
08/29/1996 | WO1996026266A1 Peptides for tissue and cell culture media |
08/29/1996 | WO1996026265A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
08/29/1996 | WO1996026219A1 Isolated dna sequence for a novel macrophage receptor with a collagenous domain and the polypeptide chain encoded by such a sequence |
08/29/1996 | WO1996026218A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
08/29/1996 | WO1996026217A1 Novel protein and methods for the production of the same |
08/29/1996 | WO1996026216A1 Novel bacteriocin piscicolin 126 |
08/29/1996 | WO1996026215A1 Ingap protein involved in pancreatic islet neogenesis |
08/29/1996 | WO1996026214A1 Isolated nonapeptides presented by hla molecules, and uses thereof |
08/29/1996 | WO1996026179A1 Novel cationic lipids and the use thereof |
08/29/1996 | WO1996025953A1 Redirection of cellular immunity by receptor chimeras |
08/29/1996 | WO1996025948A1 PREPARATION AND USE OF A SPECIFIC GABA-Aα5 RECEPTOR LIGAND FOR TREATMENT OF ALZHEIMER'S DISEASE |
08/29/1996 | WO1996025947A2 Induction of e-selectin for targetting therapeutic agents |
08/29/1996 | WO1996025946A1 HOMOLOGY OF INTERLEUKIN-1β-CONVERTASE WITH C. ELEGANS CED-3 AND INHIBITION OF CELL DEATH |
08/29/1996 | WO1996025941A1 Modulators of regulatory proteins |
08/29/1996 | WO1996018741A3 Liposome-mediated transfection of central nervous system cells |